Grosch S, Erpicum P, Bouquegneau A, Jouret F, Bovy C
Service de Néphrologie, Dialyse et Transplantation CHU Liège, Belgique.
Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Unité de Recherche Cardio-Vasculaire, ULiège, Belgique.
Rev Med Liege. 2022 May;77(5-6):330-337.
Glomerulonephritis are the result of an inflammatory hit to the glomerulus. They are rare and heterogeneous renal diseases. Each glomerular compartment can be affected. The clinical manifestations present with hematuria, proteinuria and/or impaired renal function, either isolated or combined. Two main clinico-biological syndromes are described: nephrotic syndrome and nephritic syndrome. The latter can present in a more severe form i.e. rapidly progressive glomerulonephritis with the worst prognosis. These different clinical pictures are related to specific glomerular lesions. Thus, podocytic damage is mainly responsible for nephrotic syndromes, mesangial damage is responsible for proteinuria and hematuria and, finally, endothelial damage is responsible for nephritic syndrome and rapidly progressive glomerulonephritis. Therapeutic approaches include non-specific measures, combining both life-style and pharmacological interventions with the aim to reduce risk factors, and specific measures with the use of different immunosuppressive agents.
肾小球肾炎是肾小球受到炎症冲击的结果。它们是罕见的异质性肾脏疾病。每个肾小球腔都可能受到影响。临床表现为血尿、蛋白尿和/或肾功能受损,可单独出现或合并出现。描述了两种主要的临床生物学综合征:肾病综合征和肾炎综合征。后者可表现为更严重的形式,即快速进展性肾小球肾炎,预后最差。这些不同的临床表现与特定的肾小球病变有关。因此,足细胞损伤主要导致肾病综合征,系膜损伤导致蛋白尿和血尿,最后,内皮损伤导致肾炎综合征和快速进展性肾小球肾炎。治疗方法包括非特异性措施,将生活方式和药物干预相结合以降低危险因素,以及使用不同免疫抑制剂的特异性措施。